A
The lawsuit, filed by former Vesper Medical Inc. investors, targets the Dutch conglomerate’s US unit. The suit says Philips is stiffing Vesper’s ex-owners on milestone payments stemming from regulatory approval of a breakthrough stent system used to treat obstruction of large veins in the pelvis, a condition that can lead to dangerous complications including blood clots.
“Philips’s refusal to pay the milestone to the Vesper shareholders should be seen for what it is: ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.